Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation for the Treatment of Polyendocrine Metabolic Ovarian Syndrome in Obese Women
NCT07746635Phase 2Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Apr 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in Polycystic Ovary Syndrome (PCOS), sponsored by Shanghai Changzheng Hospital. Started Apr 2025; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Polycystic Ovary Syndrome (PCOS)
Beyond the preview
Go deeper on NCT07746635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746635.